| 查看: 6411 | 回复: 30 | |||
| 当前只显示满足指定条件的回帖，点击这里查看本话题的所有回帖 | |||
金灶沐木虫 (著名写手)
|
[交流]
检索各大制药公司进入临床试验药物情况的网站 已有23人参与
|
||
|
http://sigma.larvol.com/product.php?e1=604&sourcepg=TZ 包括研发公司，药品代号（名称）、作用机制、临床适应症等。 我也是刚看到，有兴趣的话可以试试，评论一下。 [ Last edited by 金灶沐 on 2014-1-17 at 11:16 ] |
回复此楼» 本帖已获得的红花（最新10朵）
tonchin» 猜你喜欢
药学专硕申博
已经有18人回复
-
可能上不了岸？有条件的可以考虑其他出路
已经有0人回复
-
药物学论文润色/翻译怎么收费?
已经有95人回复
-
医药研发数据库资源
已经有4人回复
-
分子对接相关经验分享
已经有0人回复
-
分子对接相关经验分享
已经有0人回复
-
2026生物医药产业发展大会
已经有0人回复
-
看过往病历，有疑惑请教
已经有1人回复
-
国青中了
已经有23人回复
-
:D多个国家或地区的农药法规&登记情况查询网站
已经有0人回复
★ ★ ★
小木虫: 金币+0.5, 给个红包，谢谢回帖
金灶沐: 回帖置顶 2014-01-20 20:02:59
1949stone: 金币+2, 很满意 2014-02-22 22:25:12
小木虫: 金币+0.5, 给个红包，谢谢回帖
金灶沐: 回帖置顶 2014-01-20 20:02:59
1949stone: 金币+2, 很满意 2014-02-22 22:25:12
|
http://www.larvol.com/media/media.html The Larvol Group Launches Free Online Pharmaceutical Database of Trials and Products - Larvol Sigma San Francisco, CA – June 26, 2013 - The Larvol Group, LLC announced today that it has officially launched Larvol Sigma, a free pharmaceutical intelligence online resource developed to enable more efficient access to clinicaltrials.gov and EudraCT. With a database containing over 5,000 drugs and more than 150,000 drug trials across all major indications, Larvol Sigma is designed to meet the specific needs of investigators, researchers and industry professionals. "We are excited to share this new product," said company president Bruno Larvol. "We have worked closely with several large pharmaceutical companies to develop a user-friendly pipeline platform with advanced analytics that allows users to focus on specific diseases, companies and mechanisms of action." To view Larvol Sigma, please visit www.larvolsigma.com. The Larvol Group will be hosting a live Webinar to demonstrate the new platform's capabilities on July 30, 2013 at 9am PDT. Please visit https://www.brighttalk.com/webcast/9739/79119 for more details. About The Larvol Group, LLC: Founded in 2004, The Larvol Group (www.larvol.com) is a San Francisco-based competitive intelligence company that provides innovative business intelligence services for the pharmaceutical industry. Their customized Market Intelligence Reports track relevant news, clinical trials and developments in the competitive landscape of a given indication. Drawing on the knowledge of over 100 professionals, The Larvol Group has expertise in all major therapeutic areas, including oncology, cardiovascular disease, metabolic diseases, CNS, immunology, women's health and pain management. Their diverse portfolio of clients includes top pharmaceutical companies and small to midsized biotech firms. For more information regarding how The Larvol Group can assist your organization, please contact Natalie Gulley at natalie.gulley@larvol.com or 415.874.3310. |
24楼2014-01-20 17:05:21
liuwei_16300
新虫 (初入文坛)
- 应助: 1 (幼儿园)
- 金币: 1371.8
- 帖子: 44
- 在线: 33.4小时
- 虫号: 1321551
- 注册: 2011-06-12
- 专业: 肿瘤化学药物治疗
2楼2014-01-17 13:24:34
tianchao7133 
金虫 (正式写手)
药剂小兵
- 应助: 46 (小学生)
- 金币: 1310.4
- 散金: 32
- 红花: 11
- 帖子: 443
- 在线: 161.8小时
- 虫号: 716200
- 注册: 2009-03-06
- 性别: GG
- 专业: 药剂学
3楼2014-01-17 15:01:20
tianchao7133
金虫 (正式写手)
药剂小兵
- 应助: 46 (小学生)
- 金币: 1310.4
- 散金: 32
- 红花: 11
- 帖子: 443
- 在线: 161.8小时
- 虫号: 716200
- 注册: 2009-03-06
- 性别: GG
- 专业: 药剂学
4楼2014-01-17 16:27:21
